News - Selux Diagnostics

In the News

How New Rapid Antimicrobial Susceptibility Testing Technologies for Blood Cultures Change the Paradigm of Patient Care

January 28, 2025

Does Speed Matter? The Financial and Clinical Benefits of Rapid AST

January 28, 2025

Changing the paradigm of patient care with new rapid antimicrobial susceptibility testing technologies

January 28, 2025

Rapid AST is here to stay: Multi-site comparison of performance and time-to-results of rapid and legacy AST Systems with “gold standard” methods.

January 28, 2025

Science is a Puzzle: Selux Diagnostics Director of Research and Development Kelly Flentie On Collaboration, Idea Diversity, and Solving One of the Biggest Medical Problems of Our Time

April 26, 2022

Selux Diagnostics pulls in $50m Series C

March 3, 2022

Selux secures $50M for commercialization of antimicrobial susceptibility testing platform

March 3, 2022

Selux Diagnostics Eyes First Half of 2022 for Next-Gen AST Platform Launch

November 16, 2021

Breakthrough device designation for AST platform

October 4, 2021